Note that the content is AI-generated and might contain mistakes. Generation might take some time.
If AI keeps you waiting, feel free to play the mini-game below in the meantime!
CSD/BSE&NSE/2025-26
September 18, 2025
To
The Manager
Department of Corporate Services
BSE Limited
25th Floor, P. J. Towers,
Dalal Street, Mumbai - 400 001
To
The Manager
Listing Department
National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla Complex
Bandra (E), Mumbai – 400 051
Scrip Code: 543064
Scrip Symbol: COHANCE
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 regarding Analyst/ Institutional Investor Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, please note that the management of the Company will be attending the below mentioned conference:
Date
Conference
Location
Group/One-one
September 23, 2025
JP Morgan conference
Mumbai
Group/One-one
September 24, 2025
JP Morgan Roadshow
Hyderabad
Group/One-one
No unpublished price-sensitive information will be shared during this interaction.
Note: The schedule of the aforesaid meetings is subject to change. The change may happen due to exigencies
on the part of Analyst/ Institutional Investor/ Company.
You are requested to take this information on records.
Thanking you.
Yours faithfully,
For Cohance Lifesciences Limited
(Formerly, Suven Pharmaceuticals Limited)
Kundan Kumar Jha
Company Secretary, Compliance Officer and Head-Legal
